Abstract

BackgroundRates of medication non-adherence in dialysis patients are high, and improving adherence is likely to improve outcomes. Few data are available regarding factors associated with medication adherence in dialysis patients, and these data are needed to inform effective intervention strategies.Methods/designThis is an observational cross-sectional study of a multi-ethnic dialysis cohort from New Zealand, with the main data collection tool being an interviewer-assisted survey. A total of 100 participants were randomly sampled from a single centre, with selection stratified by ethnicity and dialysis modality (facility versus home). The main outcome measure is self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale (MMAS-8). Study data include demographic, clinical, social and psychometric characteristics, the latter being constructs of health literacy, medication knowledge, beliefs about medications, and illness perceptions. Psychometric constructs were assessed through the following survey instruments; health literacy screening questions, the Medication Knowledge Evaluation Tool (Okuyan et al.), the Beliefs about Medication Questionnaire (Horne et al.), the Brief Illness Perception Questionnaire (Broadbent et al.). Using the study data, reliability analysis for internal consistency is satisfactory for the scales evaluating health literacy, medication knowledge, and beliefs about medications, with Chronbach’s α > 0.7 for all. Reliability analysis indicated poor internal consistency for scales relating to illness perceptions. MMAS-8 and all psychometric scores are normally distributed in the study data.DiscussionThis study will provide important information on the factors involved in medication non-adherence in New Zealand dialysis patients. The resulting knowledge will inform long-term initiatives to reduce medication non-adherence in dialysis patients, and help ensure that they are addressing appropriate and evidence based targets for intervention.Electronic supplementary materialThe online version of this article (doi:10.1186/s12882-015-0097-2) contains supplementary material, which is available to authorized users.

Highlights

  • Rates of medication non-adherence in dialysis patients are high, and improving adherence is likely to improve outcomes

  • This study will provide important information on the factors involved in medication non-adherence in New Zealand dialysis patients

  • In patients with end stage kidney disease, dialysis is an effective treatment for the removal of most uremic toxins, the majority of patients require a large number of additional medications to control hyperphosphatemia, hypertension, anaemia and other biochemical consequences of their disease

Read more

Summary

Introduction

Rates of medication non-adherence in dialysis patients are high, and improving adherence is likely to improve outcomes. Few data are available regarding factors associated with medication adherence in dialysis patients, and these data are needed to inform effective intervention strategies. The total drug burden in dialysis patients can be considerable, with the median number of prescribed tablets per day ranging from 12 to 19 in recent observational studies, the highest burden of any chronic disease group [6, 7]. In a previous pilot study into medication non-adherence among haemodialysis patients at our institution, nonadherence rates were 33 % and several fold higher amongst New Zealand (NZ) Māori, Pacific Peoples and the elderly [9]

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call